
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Monoacylglycerol lipase (MAGL) as a promising therapeutic target
Ana Gil-Ordóñez, Mar Martín‐Fontecha, Silvia Ortega‐Gutiérrez, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 18-32
Closed Access | Times Cited: 104
Ana Gil-Ordóñez, Mar Martín‐Fontecha, Silvia Ortega‐Gutiérrez, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 18-32
Closed Access | Times Cited: 104
Showing 1-25 of 104 citing articles:
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 91
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 91
Piperidine Derivatives: Recent Advances in Synthesis and Pharmacological Applications
Nikita A. Frolov, A. N. Vereshchagin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2937-2937
Open Access | Times Cited: 82
Nikita A. Frolov, A. N. Vereshchagin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2937-2937
Open Access | Times Cited: 82
The role of lipid metabolic reprogramming in tumor microenvironment
Kai Yang, Xiaokun Wang, Chenghu Song, et al.
Theranostics (2023) Vol. 13, Iss. 6, pp. 1774-1808
Open Access | Times Cited: 69
Kai Yang, Xiaokun Wang, Chenghu Song, et al.
Theranostics (2023) Vol. 13, Iss. 6, pp. 1774-1808
Open Access | Times Cited: 69
Cannabis: a multifaceted plant with endless potentials
Eric Fordjour, Charles F. Manful, Albert Adu Sey, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 46
Eric Fordjour, Charles F. Manful, Albert Adu Sey, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 46
Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms
Ewa Galaj, Guo‐Hua Bi, Hongju Yang, et al.
Neuropharmacology (2019) Vol. 167, pp. 107740-107740
Open Access | Times Cited: 106
Ewa Galaj, Guo‐Hua Bi, Hongju Yang, et al.
Neuropharmacology (2019) Vol. 167, pp. 107740-107740
Open Access | Times Cited: 106
A Guide to Targeting the Endocannabinoid System in Drug Design
Adam Stasiulewicz, Katarzyna Znajdek, Monika Grudzień, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2778-2778
Open Access | Times Cited: 104
Adam Stasiulewicz, Katarzyna Znajdek, Monika Grudzień, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2778-2778
Open Access | Times Cited: 104
Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors
Noëlle van Egmond, Verena M. Straub, Mario van der Stelt
The Annual Review of Pharmacology and Toxicology (2020) Vol. 61, Iss. 1, pp. 441-463
Open Access | Times Cited: 82
Noëlle van Egmond, Verena M. Straub, Mario van der Stelt
The Annual Review of Pharmacology and Toxicology (2020) Vol. 61, Iss. 1, pp. 441-463
Open Access | Times Cited: 82
Neurobiology of cannabinoid receptor signaling
Beat Lutz
Dialogues in Clinical Neuroscience (2020) Vol. 22, Iss. 3, pp. 207-222
Open Access | Times Cited: 81
Beat Lutz
Dialogues in Clinical Neuroscience (2020) Vol. 22, Iss. 3, pp. 207-222
Open Access | Times Cited: 81
Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases
Chu Chen
Pharmacology & Therapeutics (2023) Vol. 244, pp. 108394-108394
Open Access | Times Cited: 28
Chu Chen
Pharmacology & Therapeutics (2023) Vol. 244, pp. 108394-108394
Open Access | Times Cited: 28
Impact of cannabinoids on cancer outcomes in patients receiving immune checkpoint inhibitor immunotherapy
MariaLuisa Vigano, Lixing Wang, Alia As’sadiq, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
MariaLuisa Vigano, Lixing Wang, Alia As’sadiq, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Highly Specific Miniaturized Fluorescent Monoacylglycerol Lipase Probes Enable Translational Research
Axel Hentsch, Mónica Guberman, Silke Radetzki, et al.
Journal of the American Chemical Society (2025)
Open Access | Times Cited: 1
Axel Hentsch, Mónica Guberman, Silke Radetzki, et al.
Journal of the American Chemical Society (2025)
Open Access | Times Cited: 1
2-Arachidonoylglycerol Modulation of Anxiety and Stress Adaptation: From Grass Roots to Novel Therapeutics
Gaurav Bedse, Mathew N. Hill, Sachin Patel
Biological Psychiatry (2020) Vol. 88, Iss. 7, pp. 520-530
Open Access | Times Cited: 55
Gaurav Bedse, Mathew N. Hill, Sachin Patel
Biological Psychiatry (2020) Vol. 88, Iss. 7, pp. 520-530
Open Access | Times Cited: 55
Positron Emission Tomography Imaging of the Endocannabinoid System: Opportunities and Challenges in Radiotracer Development
Lu Hou, Jian Rong, Ahmed Haider, et al.
Journal of Medicinal Chemistry (2020) Vol. 64, Iss. 1, pp. 123-149
Open Access | Times Cited: 51
Lu Hou, Jian Rong, Ahmed Haider, et al.
Journal of Medicinal Chemistry (2020) Vol. 64, Iss. 1, pp. 123-149
Open Access | Times Cited: 51
Roles of Endocannabinoids and Endocannabinoid-Like Molecules in Energy Homeostasis and Metabolic Regulation: A Nutritional Perspective
S.M. Khaledur Rahman, Toru Uyama, Zahir Hussain, et al.
Annual Review of Nutrition (2021) Vol. 41, Iss. 1, pp. 177-202
Closed Access | Times Cited: 51
S.M. Khaledur Rahman, Toru Uyama, Zahir Hussain, et al.
Annual Review of Nutrition (2021) Vol. 41, Iss. 1, pp. 177-202
Closed Access | Times Cited: 51
Chen Chen, Wei Zhao, Xingxing Lu, et al.
Cancer Science (2022) Vol. 113, Iss. 8, pp. 2600-2615
Open Access | Times Cited: 31
Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer’s Disease
Hina Kanwal, Moris Sangineto, Martina Ciarnelli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4050-4050
Open Access | Times Cited: 7
Hina Kanwal, Moris Sangineto, Martina Ciarnelli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4050-4050
Open Access | Times Cited: 7
Aberrant Lipid Metabolism in Cancer: Current Status and Emerging Therapeutic Perspectives
Rasha Irshad, Sazi Tabassum, Mohammad Husain
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 12, pp. 1090-1103
Closed Access | Times Cited: 15
Rasha Irshad, Sazi Tabassum, Mohammad Husain
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 12, pp. 1090-1103
Closed Access | Times Cited: 15
Brain structural changes in cannabis dependence: association with MAGL
Peter Manza, Kai Yuan, Ehsan Shokri‐Kojori, et al.
Molecular Psychiatry (2019) Vol. 25, Iss. 12, pp. 3256-3266
Open Access | Times Cited: 40
Peter Manza, Kai Yuan, Ehsan Shokri‐Kojori, et al.
Molecular Psychiatry (2019) Vol. 25, Iss. 12, pp. 3256-3266
Open Access | Times Cited: 40
Inhibition of 2-Arachidonoylglycerol Metabolism Alleviates Neuropathology and Improves Cognitive Function in a Tau Mouse Model of Alzheimer’s Disease
Jack Hashem, Mei Hu, Jian Zhang, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 8, pp. 4122-4133
Open Access | Times Cited: 28
Jack Hashem, Mei Hu, Jian Zhang, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 8, pp. 4122-4133
Open Access | Times Cited: 28
Development of High Brain-Penetrant and Reversible Monoacylglycerol Lipase PET Tracers for Neuroimaging
Yingfang He, Matthias Schild, Uwe Grether, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 3, pp. 2191-2207
Closed Access | Times Cited: 21
Yingfang He, Matthias Schild, Uwe Grether, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 3, pp. 2191-2207
Closed Access | Times Cited: 21
Inhibition of 2-arachidonoylglycerol degradation enhances glial immunity by single-cell transcriptomic analysis
Dexiao Zhu, Jian Zhang, Jack Hashem, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 13
Dexiao Zhu, Jian Zhang, Jack Hashem, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 13
Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. SARs, Structural Analysis, and Biological Characterization
Stefania Butini, Uwe Grether, Kwang‐Mook Jung, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 3, pp. 1758-1782
Open Access | Times Cited: 4
Stefania Butini, Uwe Grether, Kwang‐Mook Jung, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 3, pp. 1758-1782
Open Access | Times Cited: 4
Genome-wide identification and mining elite allele variation of the Monoacylglycerol lipase (MAGL) gene family in upland cotton (Gossypium hirsutum L.)
Zhibin Zhou, Yao Chen, Mengyuan Yan, et al.
BMC Plant Biology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Zhibin Zhou, Yao Chen, Mengyuan Yan, et al.
BMC Plant Biology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
The Role of Cannabinoids in Allergic Diseases: Collegium Internationale Allergologicum (CIA) Update 2020
Alba Angelina, Mario Pérez‐Diego, Jacobo López‐Abente, et al.
International Archives of Allergy and Immunology (2020) Vol. 181, Iss. 8, pp. 565-584
Open Access | Times Cited: 28
Alba Angelina, Mario Pérez‐Diego, Jacobo López‐Abente, et al.
International Archives of Allergy and Immunology (2020) Vol. 181, Iss. 8, pp. 565-584
Open Access | Times Cited: 28
Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases
Anca Zanfirescu, Anca Ungurianu, Dragoș Paul Mihai, et al.
Molecules (2021) Vol. 26, Iss. 18, pp. 5668-5668
Open Access | Times Cited: 27
Anca Zanfirescu, Anca Ungurianu, Dragoș Paul Mihai, et al.
Molecules (2021) Vol. 26, Iss. 18, pp. 5668-5668
Open Access | Times Cited: 27